Tumor necrosis factor-alpha, interleukin 2 and IgG-BF IIi (CD 16) . Evaluation of serum levels in gynecologic cancer
De Jaco, P.A.; Fridman, W.H.; Teillaud, J.L.
Presse Medicale 18(23): 1167-1168
1989
ISSN/ISBN: 0755-4982 PMID: 2525754 Document Number: 346296
Document emailed within 1 workday
Related Documents
Dunjic-Kostic, B.; Jasovic-Gasic, M.; Ivkovic, M.; Radonjic, N.V.; Pantovic, M.; Damjanovic, A.; Poznanovic, S.T.; Jovanovic, A.; Nikolic, T.; Petronijevic, N.D. 2013: Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia Psychiatria Danubina 25(1): 55-61Robak, E.; Sysa-Jedrzejewska, A.; Dziankowska, B.; Torzecka, D.; Chojnowski, K.; Robak, T. 1998: Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity Archivum Immunologiae et Therapiae Experimentalis 46(6): 375-380
Shi, B.; Nakazawa, H.; Ryoji, O.; Goya, N.; Ito, F.; Koga, S.; Okuda, H.; Kobayashi, H.; Toma, H. 1998: Study on urinary levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in patients with renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 44(3): 143-147
Alsalameh, S.; Mattka, B.; Al-Ward, R.; Lorenz, H.M.; Manger, B.; Pfizenmaier, K.; Grell, M.; Kalden, J.R. 1999: Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor Journal of Rheumatology 26(3): 645-653
Selim, K.; Hüseyin, C.; Ibrahim, K.H.; Hasan, B.U.; Kazim, U.; Hüseyin, K. 2004: Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis Medical Journal of Malaysia 59(3): 391-394
Chuncharunee, S.; Archararit, N.; Hathirat, P.; Udomsubpayakul, U.; Atichartakarn, V. 1997: Levels of serum interleukin-6 and tumor necrosis factor in postsplenectomized thalassemic patients Journal of the Medical Association of Thailand 80(Suppl 1): S86-S91
Sarno, E.N.; Grau, G.E.; Vieira, L.M.; Nery, J.A. 1991: Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states Clinical and Experimental Immunology 84(1): 103-108
Feng, J.; Chen, B.-Y.; Guo, M.-N.; Cao, J.; Zhao, H.-Y.; Liang, D.-C.; Zuo, A.-J. 2007: Interleukin-6 and tumor necrosis factor-alpha levels of endothelial cells in different hypoxia modes: in vitro experiment Zhonghua Yi Xue Za Zhi 87(11): 774-777
Laban-Guceva, N.; Bogoev, M.; Antova, M. 2007: Serum concentrations of interleukin (IL-)1alpha, 1beta, 6 and tumor necrosis factor (TNF-) alpha in patients with thyroid eye disease (TED) Medicinski Arhiv 61(4): 203-206
Alecu, M.; Geleriu, L.; Coman, G.; Gălăţescu, L. 1998: The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis Romanian Journal of Internal Medicine 36(3-4): 251-259
Castelli, C.; Sensi, M.; Lupetti, R.; Mortarini, R.; Panceri, P.; Anichini, A.; Parmiani, G. 1994: Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene Cancer Research 54(17): 4785-4790
Pichyangkul, S.; Saengkrai, P.; Webster, H.K. 1994: Plasmodium falciparum pigment induces monocytes to release high levels of tumor necrosis factor-alpha and interleukin-1 beta American Journal of Tropical Medicine and Hygiene 51(4): 430-435
Wu, S.; Rodabaugh, K.; Martinez-Maza, O.; Watson, J.M.; Silberstein, D.S.; Boyer, C.M.; Peters, W.P.; Weinberg, J.B.; Berek, J.S.; Bast, R.C. 1992: Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alpha American Journal of Obstetrics and Gynecology 166(3): 997-1007
Qiu, H.B.; Chen, D.C.; Pan, J.Q.; Liu, D.W.; Ma, S. 1999: Inhibitory effects of nitric oxide and interleukin-10 on production of tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6 in mouse alveolar macrophages Zhongguo Yao Li Xue Bao 20(3): 271-275
Yang, S.C.; Owen-Schaub, L.; Mendiguren-Rodriguez, A.; Grimm, E.A.; Hong, W.K.; Roth, J.A. 1990: Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha Journal of Thoracic and Cardiovascular Surgery 99(1): 8
Liu, Y.; Luo, L.; Zhao, H. 2000: Changes of tumor necrosis factor alpha and interleukin-6 levels in peritoneal fluid of patients with endometriosis and their effects on human sperm motility and mouse embryo development Zhonghua Fu Chan Ke Za Zhi 35(6): 332-334
Daniel, L.W.; Civoli, F.; Rogers, M.A.; Smitherman, P.K.; Raju, P.A.; Roederer, M. 1995: ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha Cancer Research 55(21): 4844-4849
Sereflican, B.; Goksugur, N.; Bugdayci, G.; Polat, M.; Haydar Parlak, A. 2016: Serum Visfatin, Adiponectin, and Tumor Necrosis Factor Alpha (TNF-α) Levels in Patients with Psoriasis and their Correlation with Disease Severity Acta Dermatovenerologica Croatica: Adc 24(1): 13-19
Villani, F.; Dell'Oca, I.; De Maria, P.; Viola, G.; Di Russo, A.; Viviani, S.; Bonfante, V. 1999: Lung function and serum concentration of tumor necrosis factor-alpha, interleukin-6 and fibronectin in patients treated with ABVD chemotherapy followed by radiotherapy for mediastinal Hodgkin's disease Anticancer Research 19(5c): 4475-4479
Gruschwitz, M.S.; Albrecht, M.; Vieth, G.; Haustein, U.F. 1997: In situ expression and serum levels of tumor necrosis factor-alpha receptors in patients with early stages of systemic sclerosis Journal of Rheumatology 24(10): 1936-1943